According to Research, the global market for Bromhidrosis Disease Treatment should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Bromhidrosis Disease Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Bromhidrosis Disease Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Topical Antiseptic segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Bromhidrosis Disease Treatment include AbbVie, Biovencer Healthcare, Boehringer Ingelheim International GmbH, Galderma SA, Hikma Pharmaceuticals, Ipsen Pharma, Johnson and Johnson, Journey Medical Corp and Medytox, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Bromhidrosis Disease Treatment. Report Highlights:
(1) Global Bromhidrosis Disease Treatment market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Bromhidrosis Disease Treatment market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Bromhidrosis Disease Treatment market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Bromhidrosis Disease Treatment segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Bromhidrosis Disease Treatment segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Bromhidrosis Disease Treatment, capacity, production and trends.
(7) Bromhidrosis Disease Treatment industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Topical Antiseptic
Antiperspirants
Botulinum Toxin
Market segment by application, can be divided into
Hospital
Drugs Store
Other
Market segment by players, this report covers
AbbVie
Biovencer Healthcare
Boehringer Ingelheim International GmbH
Galderma SA
Hikma Pharmaceuticals
Ipsen Pharma
Johnson and Johnson
Journey Medical Corp
Medytox
Merz Pharma GmbH and Co. KGaA
Novartis AG
Pfizer
1 Market Overview
1.1 Bromhidrosis Disease Treatment Definition
1.2 Global Bromhidrosis Disease Treatment Market Size and Forecast
1.2.1 By Revenue, Global Bromhidrosis Disease Treatment Market Size, 2018-2029
1.2.2 By Sales Volume, Global Bromhidrosis Disease Treatment Market Size, 2018-2029
1.2.3 Global Bromhidrosis Disease Treatment Price Trend, 2018-2029
1.3 China Bromhidrosis Disease Treatment Market Size and Forecast
1.3.1 By Revenue, China Bromhidrosis Disease Treatment Market Size, 2018-2029
1.3.2 By Sales Volume, China Bromhidrosis Disease Treatment Market Size, 2018-2029
1.3.3 China Bromhidrosis Disease Treatment Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Bromhidrosis Disease Treatment Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Bromhidrosis Disease Treatment Share in Global Market, 2018-2029
1.4.3 Bromhidrosis Disease Treatment Market Size: China VS Global, 2018-2029
1.5 Bromhidrosis Disease Treatment Market Dynamics
1.5.1 Bromhidrosis Disease Treatment Market Drivers
1.5.2 Bromhidrosis Disease Treatment Market Restraints
1.5.3 Bromhidrosis Disease Treatment Industry Trends
1.5.4 Bromhidrosis Disease Treatment Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Bromhidrosis Disease Treatment Revenue by Company, 2018-2023
2.2 Global Bromhidrosis Disease Treatment Sales Volume by Company, 2018-2023
2.3 Global Bromhidrosis Disease Treatment Price by Company, 2018-2023
2.4 Global Bromhidrosis Disease Treatment Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Bromhidrosis Disease Treatment Concentration Ratio
2.6 Global Bromhidrosis Disease Treatment Mergers & Acquisitions, Expansion Plans
2.7 Global Bromhidrosis Disease Treatment Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Bromhidrosis Disease Treatment Revenue by Company, 2018-2023
3.2 China Bromhidrosis Disease Treatment Sales Volume by Company, 2018-2023
3.3 China Bromhidrosis Disease Treatment Bromhidrosis Disease Treatment Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Bromhidrosis Disease Treatment Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Bromhidrosis Disease Treatment Domestic VS Export
3.6 China Market, Bromhidrosis Disease Treatment Import & Export
3.6.1 China Market, Bromhidrosis Disease Treatment Import & Export, 2018-2029
3.6.2 China Bromhidrosis Disease Treatment Import & Export Trends
3.6.3 Main Sources of China Bromhidrosis Disease Treatment Import
3.6.4 Export Destination of China Bromhidrosis Disease Treatment
4 Bromhidrosis Disease Treatment Production by Region
4.1 Global Bromhidrosis Disease Treatment Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Bromhidrosis Disease Treatment Manufacturers
4.3 Global Major Manufacturers, Bromhidrosis Disease Treatment Capacity Expansion and Future Plans
4.4 Global Bromhidrosis Disease Treatment Capacity by Region
4.5 Global Bromhidrosis Disease Treatment Production by Region
4.5.1 Global Bromhidrosis Disease Treatment Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Bromhidrosis Disease Treatment Production by Region, 2018-2023
4.5.3 Global Bromhidrosis Disease Treatment Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Bromhidrosis Disease Treatment Industry Chain
5.2 Bromhidrosis Disease Treatment Upstream Analysis
5.2.1 Bromhidrosis Disease Treatment Core Raw Materials
5.2.2 Main Manufacturers of Bromhidrosis Disease Treatment Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Bromhidrosis Disease Treatment Production Mode
5.6 Bromhidrosis Disease Treatment Procurement Model
5.7 Bromhidrosis Disease Treatment Industry Sales Model and Sales Channels
5.7.1 Bromhidrosis Disease Treatment Sales Model
5.7.2 Bromhidrosis Disease Treatment Typical Distributors
6 Sights by Type
6.1 Bromhidrosis Disease Treatment Classification
6.1.1 Topical Antiseptic
6.1.2 Antiperspirants
6.1.3 Botulinum Toxin
6.2 By Type, Global Bromhidrosis Disease Treatment Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Bromhidrosis Disease Treatment Revenue, 2018-2029
6.4 By Type, Global Bromhidrosis Disease Treatment Sales Volume, 2018-2029
6.5 By Type, Global Bromhidrosis Disease Treatment Price, 2018-2029
7 Sights by Application
7.1 Bromhidrosis Disease Treatment Segment by Application
7.1.1 Hospital
7.1.2 Drugs Store
7.1.3 Other
7.2 By Application, Global Bromhidrosis Disease Treatment Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Bromhidrosis Disease Treatment Revenue, 2018-2029
7.4 By Application, Global Bromhidrosis Disease Treatment Sales Volume, 2018-2029
7.5 By Application, Global Bromhidrosis Disease Treatment Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Bromhidrosis Disease Treatment Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Bromhidrosis Disease Treatment Revenue, 2018-2029
8.3 By Region, Global Bromhidrosis Disease Treatment Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Bromhidrosis Disease Treatment Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Bromhidrosis Disease Treatment Market Size Market Share
8.5 Europe
8.5.1 Europe Bromhidrosis Disease Treatment Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Bromhidrosis Disease Treatment Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Bromhidrosis Disease Treatment Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Bromhidrosis Disease Treatment Market Size Market Share
8.7 South America
8.7.1 South America Bromhidrosis Disease Treatment Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Bromhidrosis Disease Treatment Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Bromhidrosis Disease Treatment Market Size & CAGR,2018 VS 2022 VS 2029
9.2 By Country, Global Bromhidrosis Disease Treatment Revenue, 2018-2029
9.3 By Country, Global Bromhidrosis Disease Treatment Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Bromhidrosis Disease Treatment Market Size, 2018-2029
9.4.2 By Company, U.S. Bromhidrosis Disease Treatment Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Bromhidrosis Disease Treatment Market Size, 2018-2029
9.5.2 By Company, Europe Bromhidrosis Disease Treatment Sales Volume Market Share, 2022
9.5.3 By Type, Europe Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Bromhidrosis Disease Treatment Market Size, 2018-2029
9.6.2 By Company, China Bromhidrosis Disease Treatment Sales Volume Market Share, 2022
9.6.3 By Type, China Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Bromhidrosis Disease Treatment Market Size, 2018-2029
9.7.2 By Company, Japan Bromhidrosis Disease Treatment Sales Volume Market Share, 2022
9.7.3 By Type, Japan Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Bromhidrosis Disease Treatment Market Size, 2018-2029
9.8.2 By Company, South Korea Bromhidrosis Disease Treatment Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Bromhidrosis Disease Treatment Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Bromhidrosis Disease Treatment Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Bromhidrosis Disease Treatment Market Size, 2018-2029
9.10.2 By Company, India Bromhidrosis Disease Treatment Sales Volume Market Share, 2022
9.10.3 By Type, India Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Bromhidrosis Disease Treatment Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Bromhidrosis Disease Treatment Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Bromhidrosis Disease Treatment Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 AbbVie
10.1.1 AbbVie Company Information, Head Office, Market Area and Industry Position
10.1.2 AbbVie Bromhidrosis Disease Treatment Models, Specifications and Application
10.1.3 AbbVie Bromhidrosis Disease Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 AbbVie Company Profile and Main Business
10.1.5 AbbVie Recent Developments
10.2 Biovencer Healthcare
10.2.1 Biovencer Healthcare Company Information, Head Office, Market Area and Industry Position
10.2.2 Biovencer Healthcare Bromhidrosis Disease Treatment Models, Specifications and Application
10.2.3 Biovencer Healthcare Bromhidrosis Disease Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Biovencer Healthcare Company Profile and Main Business
10.2.5 Biovencer Healthcare Recent Developments
10.3 Boehringer Ingelheim International GmbH
10.3.1 Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area and Industry Position
10.3.2 Boehringer Ingelheim International GmbH Bromhidrosis Disease Treatment Models, Specifications and Application
10.3.3 Boehringer Ingelheim International GmbH Bromhidrosis Disease Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Boehringer Ingelheim International GmbH Company Profile and Main Business
10.3.5 Boehringer Ingelheim International GmbH Recent Developments
10.4 Galderma SA
10.4.1 Galderma SA Company Information, Head Office, Market Area and Industry Position
10.4.2 Galderma SA Bromhidrosis Disease Treatment Models, Specifications and Application
10.4.3 Galderma SA Bromhidrosis Disease Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Galderma SA Company Profile and Main Business
10.4.5 Galderma SA Recent Developments
10.5 Hikma Pharmaceuticals
10.5.1 Hikma Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.5.2 Hikma Pharmaceuticals Bromhidrosis Disease Treatment Models, Specifications and Application
10.5.3 Hikma Pharmaceuticals Bromhidrosis Disease Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Hikma Pharmaceuticals Company Profile and Main Business
10.5.5 Hikma Pharmaceuticals Recent Developments
10.6 Ipsen Pharma
10.6.1 Ipsen Pharma Company Information, Head Office, Market Area and Industry Position
10.6.2 Ipsen Pharma Bromhidrosis Disease Treatment Models, Specifications and Application
10.6.3 Ipsen Pharma Bromhidrosis Disease Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Ipsen Pharma Company Profile and Main Business
10.6.5 Ipsen Pharma Recent Developments
10.7 Johnson and Johnson
10.7.1 Johnson and Johnson Company Information, Head Office, Market Area and Industry Position
10.7.2 Johnson and Johnson Bromhidrosis Disease Treatment Models, Specifications and Application
10.7.3 Johnson and Johnson Bromhidrosis Disease Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Johnson and Johnson Company Profile and Main Business
10.7.5 Johnson and Johnson Recent Developments
10.8 Journey Medical Corp
10.8.1 Journey Medical Corp Company Information, Head Office, Market Area and Industry Position
10.8.2 Journey Medical Corp Bromhidrosis Disease Treatment Models, Specifications and Application
10.8.3 Journey Medical Corp Bromhidrosis Disease Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Journey Medical Corp Company Profile and Main Business
10.8.5 Journey Medical Corp Recent Developments
10.9 Medytox
10.9.1 Medytox Company Information, Head Office, Market Area and Industry Position
10.9.2 Medytox Bromhidrosis Disease Treatment Models, Specifications and Application
10.9.3 Medytox Bromhidrosis Disease Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Medytox Company Profile and Main Business
10.9.5 Medytox Recent Developments
10.10 Merz Pharma GmbH and Co. KGaA
10.10.1 Merz Pharma GmbH and Co. KGaA Company Information, Head Office, Market Area and Industry Position
10.10.2 Merz Pharma GmbH and Co. KGaA Bromhidrosis Disease Treatment Models, Specifications and Application
10.10.3 Merz Pharma GmbH and Co. KGaA Bromhidrosis Disease Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Merz Pharma GmbH and Co. KGaA Company Profile and Main Business
10.10.5 Merz Pharma GmbH and Co. KGaA Recent Developments
10.11 Novartis AG
10.11.1 Novartis AG Company Information, Head Office, Market Area and Industry Position
10.11.2 Novartis AG Bromhidrosis Disease Treatment Models, Specifications and Application
10.11.3 Novartis AG Bromhidrosis Disease Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Novartis AG Company Profile and Main Business
10.11.5 Novartis AG Recent Developments
10.12 Pfizer
10.12.1 Pfizer Company Information, Head Office, Market Area and Industry Position
10.12.2 Pfizer Bromhidrosis Disease Treatment Models, Specifications and Application
10.12.3 Pfizer Bromhidrosis Disease Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Pfizer Company Profile and Main Business
10.12.5 Pfizer Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|